Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
17/07/2026
Platinum main contract fell 4% intraday, now trading at 398.25 yuan.
Latest
2 m ago
QuestMobile: DouShengSheng user scale approaches Dianping
4 m ago
Olin Biology announced that it has recently noticed some untrue comments on certain online platforms regarding the Phase III clinical trial data of the company's recombinant Staphylococcus aureus vaccine. The 73.25% protection efficacy data disclosed by the company from the Phase III clinical trial results was calculated by an independent third-party statistical team, and the company truthfully made information disclosure based on the report issued by this independent third party. Upon verification, it was found that the data used in the online circulated "Recombinant Staphylococcus aureus Vaccine Phase III Clinical Data Audit Report," such as the number of confirmed cases, total number of subjects, and the conclusions, are inconsistent with the actual situation of the company's clinical trials.
4 m ago
Mega Chipsecurity and Sweet Potato Robotics have reached a strategic cooperation agreement to jointly accelerate the scale development of the physical industry.
5 m ago
The Nikkei 225 index fell further to a 5% decrease.
6 m ago
EOPTOLINK is reportedly planning to submit a Hong Kong listing application of up to $5 billion.
See all latest